Warsaw, Ind.-based Zimmer Holdings' board of directors has approved a quarterly dividend payment to stockholders for the fourth quarter of 2013.
Spinal Tech
Cambridge, Mass.-based InVivo Therapeutics has named Steven McAllister as its interim CFO as of Dec. 31.
After meeting recently, a U.S. Food and Drug Administration committee agreed spinal sphere devices should be classified as Class 3 devices, which require premarket approval, according to a Medscape report.
The 3-D printing market for medical device applications is anticipated to grow 15.4 percent from 2013 to 2019, according to a Transparency Market Research report.
Columbus, Ohio's Third Frontier Commission approved $6.5 million for the Commercial Acceleration Loan Fund's first round, including $1.6 million to Akron-based Intellirod Spine.
Advertisement
Integra LifeSciences announced the publication of a clinical study that showed that using its NeuraGen Nerve Guide resulted in less operation time and lower post-operative pain than direct suture repair in patients who had complete traumatic nerve injuries.
Mazor Robotics announced that it will be included in the Tel Aviv Stock Exchange Top 75 Index and Top 100 Index, effective Dec. 15.
Medtronic and Cardinal Health have partnered with Ohio State University in Columbus to provide $42 million in funding for neuroscience technology development, according to a Mass Device report.
Arthrex's $85 million patent infringement loss to Smith & Nephew has been rejected by the U.S. Supreme Court, who has declined to hear Arthrex's appeal, according to a Mass Device report.
Hologic has appointed former Stryker executive Stephen MacMillan as its CEO, according to a Bloomberg report.